Our latest work highlights how menopause alters insulin sensitivity and diabetes management, yet the intersection remains under-researched. This study explores how menopause stages impact diabetes outcomes.
Our research found that diabetes keeps many awake at night due to symptoms, complications, and comorbidities of diabetes.
Our quarterly U.S. survey shows diabetes sharply reduces productivity and daily-life capacity—evidence that employers must offer stronger support.
Our quarterly U.S. diabetes survey found one-third of respondents had mild or severe depression, underscoring the need for more support and better treatments.
Erik Shoger presented real-world patient insights at the FDA advisory meeting on sotagliflozin, highlighting the need for education and training if approved.
